May 19, 2024, 09:02
Aleix Prat: HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants
Aleix Prat, CoFounder of Reveal Genomics, shared a post on X:
“HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study.
Led by Francesco Schettini, Matteo Lambertini.”
Read further.
Source: Aleix Prat/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 11:52
Dec 21, 2024, 11:30
Dec 21, 2024, 11:25
Dec 21, 2024, 11:18
Dec 21, 2024, 11:12
Dec 21, 2024, 11:06